Show them the money: a multi-stakeholder perspective on reforming clinical trial participant compensation

Gunnar Esiason,Angela Pontius,Luke Gelinas
DOI: https://doi.org/10.1038/d41573-024-00107-2
IF: 112.288
2024-07-19
Nature Reviews Drug Discovery
Abstract:Clinical trial participant compensation is badly overdue for thoughtful reform. The first step: generating consensus across the various stakeholders, including patients, who make up the research ecosystem. Clinical trial participant compensation is badly overdue for thoughtful reform. The first step: generating consensus across the various stakeholders, including patients, who make up the research ecosystem.
pharmacology & pharmacy,biotechnology & applied microbiology
What problem does this paper attempt to address?